Hackensack Meridian Health announces it will use EdgeNet, NJEdge’s optical fiber network, for low latency, secure, high-speed internet access.
The peering connections provided by EdgeNet will take the majority of Hackensack Meridian Health’s traffic off the commodity internet – improving speed, reliability, availability and network performance on Internet2, a not-for-profit United States computer networking consortium led by members from the research and education communities, industry and government.
“Partnering with NJEdge allows Hackensack Meridian Health to reach for new big data opportunities,” said David Reis, Ph.D., executive vice president, chief information officer of Hackensack Meridian Health. “I’m excited to bring Internet2 to Hackensack Meridian Health, which provides us new possibilities for collaborative research. Being on Internet2 demonstrates that Hackensack Meridian Health and research innovation go hand-in-hand.”
Hackensack Meridian Health’s presence on Internet2 will provide the capability to collaborate on and participate in research grants including those from the National Institutes of Health (NIH).
“We’re excited to work with New Jersey’s largest health network and provide a connection to the nationwide research community via EdgeNet,” said Dr. Samuel Conn, president & CEO of NJEdge. “By connecting Hackensack Meridian Health to Internet2 and a growing collaborative research infrastructure, we’re working to advance the cause of scientific discovery in the state and stake a claim as leaders in the research space.”
This new program from NJEdge is designed to create a level playing field for university researchers who need high-speed networking resources in order to collaborate with their colleagues.
All parts of the Hackensack Meridian Health will benefit from this high-speed access from the Hackensack Meridian School of Medicine at Seton Hall University to the John Theurer Cancer Center, which recently received approval from the National Cancer Institute as a research consortium member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center Consortium to the Center for Discovery and Innovation, which was just awarded a record $33.3 million NIH grant to develop new antibiotics to overcome deadly bacteria in hospitals that have become resistant to current treatments.
“This high-speed, low latency peering capability brings top tier research network services to Hackensack Meridian Health that we will benefit from now and well into the future,” Reis said.
To access more business news, visit NJB News Now.Related Articles: